BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 21, 2011
View Archived Issues
COR-II and substudy evaluate weight loss and blood pressure during Contrave treatment of obesity
Read More
Amira Pharma claims new arachidonate 5-lipoxygenase inhibitors
Read More
Astellas launches new tablet formulation of Vesicare for overactive bladder
Read More
Novel PARP-1 inhibitor HYDAMTIQ is efficacious in models of brain ischemia
Read More
FDA approves Rituxan for Wegener's granulomatosis and microscopic polyangiitis
Read More
BioSante Pharma licenses cancer vaccines to Aduro BioTech
Read More
PET tracer BAY-86-4367 is safe in subjects with primary prostate cancer in phase I study
Read More
Expression of transient receptor potential TRPM7 channel predicts poor survival in NPC
Read More
Baxter enters definitive agreement to acquire Prism Pharmaceuticals
Read More
Presidio Pharma updates progress of HCV NS5A inhibitors PPI-461, PPI-437, PPI-668 and PPI-833
Read More
CH-5424802 shows promise in ALK-positive tumors and advances in phase I/II trial in NSCLC
Read More
Clopidogrel reduces obliterative airways disease after trachea transplantation in mice
Read More
University of Illinois patents new integrin alpha-IIb/beta-3 antagonists
Read More
University of California presents new bladder cancer-specific ligand peptides
Read More
SciClone acquires NovaMed Pharmaceuticals
Read More
Marina Biotech completes enrollment of first cohort in START-FAP trial of CEQ-508
Read More
Osta Biotechnologies announces promising preclinical results for OB-28 in Alzheimer's disease
Read More
Biothera's second phase II trial of Imprime PGG in NSCLC achieves stage-1 endpoint
Read More
New inhibitors of hepatocyte growth factor receptor designed
Read More
Genmab and Seattle Genetics form second antibody-drug conjugate collaboration
Read More
New modulators of nuclear receptor related 1 receptor claimed
Read More
DiaMedica reports preclinical data on DM-204 in type 2 diabetes
Read More
Oncolytics Biotech reports interim data from Reolysin trial in metastatic colorectal cancer
Read More
Novel 11-beta-HSD1 inhibitors reported by University of Edinburgh
Read More
Dynavax commences first phase I trial of DV-1179 in lupus
Read More
Enrollment open in phase IIb trial of intravenous omecamtiv mecarbil in acute heart failure
Read More